S&P/TSX Composite Index Ends 0.06% Higher at 21656.05 — Data Talk
The S&P/TSX Composite Index is up 13.18 points or 0.06% today to 21656.05
--Largest one-day point and percentage gain since Tuesday, April 9, 2024
--Snaps a five-trading-day losing streak
--Off 3.16% from its record close of 22361.78 hit Tuesday, April 9, 2024
--Off 3.16% from its 52-week high of 22361.78 hit Tuesday, April 9, 2024
--Up 15.58% from its 52-week low of 18737.39 hit Friday, Oct. 27, 2023
--Rose 4.72% from 52 weeks ago
--Off 3.16% from its 2024 closing high of 22361.78 hit Tuesday, April 9, 2024
--Up 5.20% from its 2024 closing low of 20584.97 hit Tuesday, Feb. 13, 2024
--Month-to-date it is down 2.31%
--Year-to-date it is up 697.61 points or 3.33%
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 17, 2024 17:14 ET (21:14 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track